In the United States, more than 2600 kidneys are discarded annually, from the total number
of kidneys procured for transplant. We hypothesized that this organ pool may be used as a …

Decellularized adipose tissue (DAT) has shown promise as an adipogenic bioscaffold for
soft tissue augmentation and reconstruction. The objective of the current study was to …

The prevalence of kidney diseases is emerging as a public health problem. Stem cells
(SCs), currently considered as a promising tool for therapeutic application, have aroused …

Emergent technologies of regenerative medicine have the potential to overcome the
limitations of organ transplantation by supplying tissues and organs bioengineered in the …

The human placenta, a complex organ, which facilitates exchange between the fetus and
the mother, contains abundant extracellular matrix (ECM) components and well-preserved …

Organ transplantation is now a well-established procedure for the treatment of end-stage
organ failure due to various causes, but is a victim of its own success in that there is a …

This overview traces the history of regenerative medicine pertinent to organ transplantation,
illustrates potential clinical applications reported to date, and highlights progress achieved …

The natural extracellular matrix (ECM), thanks to its specific properties (eg, collagenous
lattice, a reservoir of growth factors, ECM‐cell anchoring areas, an optimal pH and CO2) …

Biologic scaffold materials composed of allogeneic or xenogeneic extracellular matrix are
commonly used for the repair and functional reconstruction of injured and missing tissues …

The definitive treatment for end-stage renal disease is kidney transplantation, which remains
limited by organ availability and post-transplant complications. Alternatively, an implantable …